Hemoglobin increases endothelin-1 in endothelial cells by decreasing nitric oxide

Area of Science:

• Vascular Biology
• Endothelial Cell Function
• Molecular Mechanisms

Background:

• Endothelin-1 (ET-1) is a potent vasoconstrictor.
• Hemoglobin's role in regulating ET-1 in cerebral arteries is not fully understood.
• Endothelial cells play a key role in vascular homeostasis.

Purpose of the Study:

• To investigate if ferrous hemoglobin stimulates ET-1 secretion from bovine cerebral artery endothelial cells.
• To elucidate the molecular mechanisms underlying hemoglobin-induced ET-1 production.
• To examine the interaction between nitric oxide and hemoglobin in regulating ET-1.

Main Methods:

• Primary bovine cerebral artery endothelial cells were exposed to varying concentrations of hemoglobin.
• Gene expression (mRNA) and peptide levels of pre-proET-1 were quantified.
• Inhibitors of protein synthesis (cycloheximide) and transcription (actinomycin D) were used.
• The effects of nitric oxide synthase inhibition (N(G)-nitro-l-arginine) and cGMP analogs (8-Bromo-cGMP) were assessed.

Main Results:

• Hemoglobin exposure led to dose-dependent increases in pre-proET-1 mRNA and peptide.
• Protein synthesis and transcription are required for hemoglobin-induced ET-1 release.
• Nitric oxide production normally inhibits ET-1 release.
• Ferrous hemoglobin's effect is partly mediated by scavenging nitric oxide, reducing its inhibitory action.
• Methemoglobin and S-nitrosylated methemoglobin were weaker stimulators of ET-1 release.

Conclusions:

• Ferrous hemoglobin increases ET-1 secretion in cerebral endothelial cells via transcriptional and translational mechanisms.
• Nitric oxide exerts an inhibitory effect on ET-1 production, which is counteracted by ferrous hemoglobin.
• The interaction between hemoglobin and the nitric oxide pathway is a significant factor in regulating cerebral ET-1 levels.